AAFPRS President Addresses Concerns About Moderna COVID-19 Vaccine
AAFPRS will continue monitoring reports of incidents of reactions in patients with dermal fillers who received the Moderna COVID-19 vaccine.
AAFPRS will continue monitoring reports of incidents of reactions in patients with dermal fillers who received the Moderna COVID-19 vaccine.
The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.